Princess Máxima Center in Utrecht, The Netherlands, have ordered a DrugLog® system to be used for quality assurance of two compounding robots that are used for reconstitution of pharmaceuticals. The order will be booked in the first quarter.
The recently opened Princess Máxima Center (PMC) is a unique hospital, being the biggest pediatric oncology center in Europe. The new center brings together all the highly complex care and research for children with cancer in the Netherlands. Around 600 children in the Netherlands get cancer every year. The Hospitla Pharmacy will take care of most of the drug preparations to the ward departments at the center and for that purpose they have bought two IV robots that will prepare drugs in an automated manner. To perform daily quality control tests contributing to the quality assurance of the robots the pharmacy department also decided to buy a DrugLog® device.
Kent Öbrink, Sales & Marketing Manager commented: “I am happy and honored to sign the first DrugLog® order in the Netherlands. PMC will serve as a role model for other European countries interested in this concept of treating childhood cancer in one place. It is also proof that our DrugLog® has an important role to play in modern drug preparation. PMC will act as an important reference institution for not only the Dutch market but for the whole of Western Europe.”
Rogier Lange, Hospital Pharmacist and Head of the Compounding Department of the Pharmacy commented: “We are convinced that the DrugLog will play an important role in the quality assurance of our IV robots. Moreover, we see possibilities for using DrugLog® in the personal qualification of personnel for manual preparation.”
This information is insider information that Pharmacolog AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact person set out above, on April 5, 2019 at 10:00.
About Pharmacolog AB
Pharmacolog is specialized in developing systems and solutions for more effective and safer use of intravenous drugs. The company’s first product, DrugLog®, enables a nurse or pharmacist to quickly and easily verify that an injectable drug has the right identity and concentration. Pharmacolog’s long-term vision is an individually optimized medication for each individual patient, considering all available parameters in the control and distribution of the drug. Further information regarding the company is available at http://www.pharmacolog.com. The company’s Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.